nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP2E1—prostate cancer	0.146	0.382	CbGaD
Felbamate—CYP2C19—prostate cancer	0.145	0.378	CbGaD
Felbamate—CYP3A4—prostate cancer	0.0921	0.24	CbGaD
Felbamate—CYP2C19—Bicalutamide—prostate cancer	0.0378	0.102	CbGbCtD
Felbamate—CYP2C19—Nilutamide—prostate cancer	0.0378	0.102	CbGbCtD
Felbamate—CYP2E1—Estrone—prostate cancer	0.0361	0.0975	CbGbCtD
Felbamate—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0348	0.0939	CbGbCtD
Felbamate—CYP2C19—Flutamide—prostate cancer	0.0313	0.0846	CbGbCtD
Felbamate—CYP2E1—Mitoxantrone—prostate cancer	0.0215	0.058	CbGbCtD
Felbamate—CYP3A4—Bicalutamide—prostate cancer	0.0183	0.0493	CbGbCtD
Felbamate—CYP3A4—Estramustine—prostate cancer	0.017	0.0459	CbGbCtD
Felbamate—CYP3A4—Abiraterone—prostate cancer	0.0151	0.0409	CbGbCtD
Felbamate—CYP3A4—Flutamide—prostate cancer	0.0151	0.0409	CbGbCtD
Felbamate—CYP2E1—Etoposide—prostate cancer	0.0135	0.0366	CbGbCtD
Felbamate—CYP2C19—Estradiol—prostate cancer	0.013	0.0351	CbGbCtD
Felbamate—CYP3A4—Cabazitaxel—prostate cancer	0.0112	0.0302	CbGbCtD
Felbamate—CYP2C19—Prednisone—prostate cancer	0.0112	0.0302	CbGbCtD
Felbamate—CYP3A4—Estrone—prostate cancer	0.0109	0.0296	CbGbCtD
Felbamate—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00975	0.0263	CbGbCtD
Felbamate—CYP3A4—Conjugated Estrogens—prostate cancer	0.00716	0.0193	CbGbCtD
Felbamate—CYP3A4—Mitoxantrone—prostate cancer	0.0065	0.0176	CbGbCtD
Felbamate—CYP3A4—Estradiol—prostate cancer	0.00628	0.017	CbGbCtD
Felbamate—CYP3A4—Prednisone—prostate cancer	0.0054	0.0146	CbGbCtD
Felbamate—CYP3A4—Etoposide—prostate cancer	0.0041	0.0111	CbGbCtD
Felbamate—CYP3A4—Docetaxel—prostate cancer	0.00375	0.0101	CbGbCtD
Felbamate—CYP3A4—Doxorubicin—prostate cancer	0.0028	0.00756	CbGbCtD
Felbamate—CYP2C19—urine—prostate cancer	0.000626	0.233	CbGeAlD
Felbamate—CYP2E1—urine—prostate cancer	0.00046	0.171	CbGeAlD
Felbamate—L-Phenylalanine—TH—prostate cancer	0.000455	1	CrCbGaD
Felbamate—CYP3A4—urine—prostate cancer	0.00037	0.138	CbGeAlD
Felbamate—GRIN3A—testis—prostate cancer	0.000299	0.111	CbGeAlD
Felbamate—GRIN2A—testis—prostate cancer	0.000236	0.0881	CbGeAlD
Felbamate—CYP2E1—prostate gland—prostate cancer	0.000165	0.0616	CbGeAlD
Felbamate—CYP2E1—seminal vesicle—prostate cancer	0.00014	0.0521	CbGeAlD
Felbamate—CYP2E1—renal system—prostate cancer	0.000113	0.042	CbGeAlD
Felbamate—CYP2E1—urethra—prostate cancer	0.000111	0.0412	CbGeAlD
Felbamate—CYP3A4—renal system—prostate cancer	9.06e-05	0.0338	CbGeAlD
Felbamate—CYP2E1—testis—prostate cancer	7.28e-05	0.0271	CbGeAlD
Felbamate—Pneumonia—Doxorubicin—prostate cancer	3.88e-05	0.000229	CcSEcCtD
Felbamate—Gastrointestinal pain—Etoposide—prostate cancer	3.88e-05	0.000229	CcSEcCtD
Felbamate—Ill-defined disorder—Prednisone—prostate cancer	3.87e-05	0.000228	CcSEcCtD
Felbamate—Thrombocytopenia—Docetaxel—prostate cancer	3.86e-05	0.000228	CcSEcCtD
Felbamate—Rash—Estradiol—prostate cancer	3.86e-05	0.000228	CcSEcCtD
Felbamate—Dermatitis—Estradiol—prostate cancer	3.86e-05	0.000228	CcSEcCtD
Felbamate—Anaemia—Prednisone—prostate cancer	3.85e-05	0.000228	CcSEcCtD
Felbamate—Confusional state—Capecitabine—prostate cancer	3.85e-05	0.000227	CcSEcCtD
Felbamate—Tachycardia—Docetaxel—prostate cancer	3.85e-05	0.000227	CcSEcCtD
Felbamate—Headache—Estradiol—prostate cancer	3.84e-05	0.000227	CcSEcCtD
Felbamate—Agitation—Prednisone—prostate cancer	3.83e-05	0.000226	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	3.83e-05	0.000226	CcSEcCtD
Felbamate—Oedema—Capecitabine—prostate cancer	3.82e-05	0.000226	CcSEcCtD
Felbamate—Bradycardia—Epirubicin—prostate cancer	3.81e-05	0.000225	CcSEcCtD
Felbamate—Infection—Capecitabine—prostate cancer	3.8e-05	0.000224	CcSEcCtD
Felbamate—Urticaria—Etoposide—prostate cancer	3.77e-05	0.000223	CcSEcCtD
Felbamate—Haemoglobin—Epirubicin—prostate cancer	3.77e-05	0.000222	CcSEcCtD
Felbamate—Jaundice—Doxorubicin—prostate cancer	3.76e-05	0.000222	CcSEcCtD
Felbamate—Anorexia—Docetaxel—prostate cancer	3.76e-05	0.000222	CcSEcCtD
Felbamate—Malaise—Prednisone—prostate cancer	3.76e-05	0.000222	CcSEcCtD
Felbamate—Rhinitis—Epirubicin—prostate cancer	3.76e-05	0.000222	CcSEcCtD
Felbamate—Abdominal pain—Etoposide—prostate cancer	3.75e-05	0.000222	CcSEcCtD
Felbamate—Body temperature increased—Etoposide—prostate cancer	3.75e-05	0.000222	CcSEcCtD
Felbamate—Urinary tract infection—Doxorubicin—prostate cancer	3.75e-05	0.000222	CcSEcCtD
Felbamate—Conjunctivitis—Doxorubicin—prostate cancer	3.75e-05	0.000222	CcSEcCtD
Felbamate—Haemorrhage—Epirubicin—prostate cancer	3.75e-05	0.000221	CcSEcCtD
Felbamate—Hepatitis—Epirubicin—prostate cancer	3.75e-05	0.000221	CcSEcCtD
Felbamate—Thrombocytopenia—Capecitabine—prostate cancer	3.74e-05	0.000221	CcSEcCtD
Felbamate—Tachycardia—Capecitabine—prostate cancer	3.73e-05	0.00022	CcSEcCtD
Felbamate—Pharyngitis—Epirubicin—prostate cancer	3.72e-05	0.00022	CcSEcCtD
Felbamate—Sweating—Doxorubicin—prostate cancer	3.7e-05	0.000219	CcSEcCtD
Felbamate—Hyperhidrosis—Capecitabine—prostate cancer	3.69e-05	0.000218	CcSEcCtD
Felbamate—Hypotension—Docetaxel—prostate cancer	3.69e-05	0.000218	CcSEcCtD
Felbamate—Haematuria—Doxorubicin—prostate cancer	3.68e-05	0.000217	CcSEcCtD
Felbamate—Epistaxis—Doxorubicin—prostate cancer	3.64e-05	0.000215	CcSEcCtD
Felbamate—Anorexia—Capecitabine—prostate cancer	3.64e-05	0.000215	CcSEcCtD
Felbamate—Nausea—Estradiol—prostate cancer	3.64e-05	0.000215	CcSEcCtD
Felbamate—Vomiting—Mitoxantrone—prostate cancer	3.63e-05	0.000214	CcSEcCtD
Felbamate—Sinusitis—Doxorubicin—prostate cancer	3.62e-05	0.000214	CcSEcCtD
Felbamate—Visual impairment—Epirubicin—prostate cancer	3.61e-05	0.000213	CcSEcCtD
Felbamate—Agranulocytosis—Doxorubicin—prostate cancer	3.6e-05	0.000213	CcSEcCtD
Felbamate—Hypertension—Prednisone—prostate cancer	3.6e-05	0.000213	CcSEcCtD
Felbamate—Rash—Mitoxantrone—prostate cancer	3.6e-05	0.000213	CcSEcCtD
Felbamate—Dermatitis—Mitoxantrone—prostate cancer	3.6e-05	0.000212	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.59e-05	0.000212	CcSEcCtD
Felbamate—Headache—Mitoxantrone—prostate cancer	3.58e-05	0.000211	CcSEcCtD
Felbamate—Hypotension—Capecitabine—prostate cancer	3.57e-05	0.000211	CcSEcCtD
Felbamate—Insomnia—Docetaxel—prostate cancer	3.57e-05	0.000211	CcSEcCtD
Felbamate—Myalgia—Prednisone—prostate cancer	3.55e-05	0.00021	CcSEcCtD
Felbamate—Arthralgia—Prednisone—prostate cancer	3.55e-05	0.00021	CcSEcCtD
Felbamate—Paraesthesia—Docetaxel—prostate cancer	3.54e-05	0.000209	CcSEcCtD
Felbamate—Erythema multiforme—Epirubicin—prostate cancer	3.54e-05	0.000209	CcSEcCtD
Felbamate—Anxiety—Prednisone—prostate cancer	3.54e-05	0.000209	CcSEcCtD
Felbamate—Bradycardia—Doxorubicin—prostate cancer	3.53e-05	0.000208	CcSEcCtD
Felbamate—Dyspnoea—Docetaxel—prostate cancer	3.52e-05	0.000208	CcSEcCtD
Felbamate—Somnolence—Docetaxel—prostate cancer	3.51e-05	0.000207	CcSEcCtD
Felbamate—Discomfort—Prednisone—prostate cancer	3.51e-05	0.000207	CcSEcCtD
Felbamate—Haemoglobin—Doxorubicin—prostate cancer	3.48e-05	0.000206	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.48e-05	0.000206	CcSEcCtD
Felbamate—Flushing—Epirubicin—prostate cancer	3.48e-05	0.000205	CcSEcCtD
Felbamate—Rhinitis—Doxorubicin—prostate cancer	3.47e-05	0.000205	CcSEcCtD
Felbamate—Dyspepsia—Docetaxel—prostate cancer	3.47e-05	0.000205	CcSEcCtD
Felbamate—Hepatitis—Doxorubicin—prostate cancer	3.47e-05	0.000205	CcSEcCtD
Felbamate—Haemorrhage—Doxorubicin—prostate cancer	3.47e-05	0.000205	CcSEcCtD
Felbamate—Insomnia—Capecitabine—prostate cancer	3.46e-05	0.000204	CcSEcCtD
Felbamate—Pharyngitis—Doxorubicin—prostate cancer	3.44e-05	0.000203	CcSEcCtD
Felbamate—Paraesthesia—Capecitabine—prostate cancer	3.43e-05	0.000203	CcSEcCtD
Felbamate—Decreased appetite—Docetaxel—prostate cancer	3.43e-05	0.000203	CcSEcCtD
Felbamate—Asthenia—Etoposide—prostate cancer	3.41e-05	0.000201	CcSEcCtD
Felbamate—Dyspnoea—Capecitabine—prostate cancer	3.41e-05	0.000201	CcSEcCtD
Felbamate—Anaphylactic shock—Prednisone—prostate cancer	3.4e-05	0.000201	CcSEcCtD
Felbamate—Oedema—Prednisone—prostate cancer	3.4e-05	0.000201	CcSEcCtD
Felbamate—Fatigue—Docetaxel—prostate cancer	3.4e-05	0.000201	CcSEcCtD
Felbamate—Nausea—Mitoxantrone—prostate cancer	3.39e-05	0.0002	CcSEcCtD
Felbamate—Infection—Prednisone—prostate cancer	3.38e-05	0.0002	CcSEcCtD
Felbamate—Constipation—Docetaxel—prostate cancer	3.37e-05	0.000199	CcSEcCtD
Felbamate—Pain—Docetaxel—prostate cancer	3.37e-05	0.000199	CcSEcCtD
Felbamate—Dyspepsia—Capecitabine—prostate cancer	3.36e-05	0.000199	CcSEcCtD
Felbamate—Chills—Epirubicin—prostate cancer	3.36e-05	0.000199	CcSEcCtD
Felbamate—Pruritus—Etoposide—prostate cancer	3.36e-05	0.000198	CcSEcCtD
Felbamate—Visual impairment—Doxorubicin—prostate cancer	3.34e-05	0.000197	CcSEcCtD
Felbamate—Tachycardia—Prednisone—prostate cancer	3.32e-05	0.000196	CcSEcCtD
Felbamate—Decreased appetite—Capecitabine—prostate cancer	3.32e-05	0.000196	CcSEcCtD
Felbamate—Alopecia—Epirubicin—prostate cancer	3.31e-05	0.000196	CcSEcCtD
Felbamate—Fatigue—Capecitabine—prostate cancer	3.29e-05	0.000195	CcSEcCtD
Felbamate—Hyperhidrosis—Prednisone—prostate cancer	3.29e-05	0.000194	CcSEcCtD
Felbamate—Erythema multiforme—Doxorubicin—prostate cancer	3.28e-05	0.000194	CcSEcCtD
Felbamate—Pain—Capecitabine—prostate cancer	3.27e-05	0.000193	CcSEcCtD
Felbamate—Constipation—Capecitabine—prostate cancer	3.27e-05	0.000193	CcSEcCtD
Felbamate—Feeling abnormal—Docetaxel—prostate cancer	3.25e-05	0.000192	CcSEcCtD
Felbamate—Diarrhoea—Etoposide—prostate cancer	3.25e-05	0.000192	CcSEcCtD
Felbamate—Anorexia—Prednisone—prostate cancer	3.24e-05	0.000192	CcSEcCtD
Felbamate—Gastrointestinal pain—Docetaxel—prostate cancer	3.23e-05	0.000191	CcSEcCtD
Felbamate—Flushing—Doxorubicin—prostate cancer	3.22e-05	0.00019	CcSEcCtD
Felbamate—Flatulence—Epirubicin—prostate cancer	3.21e-05	0.00019	CcSEcCtD
Felbamate—Tension—Epirubicin—prostate cancer	3.2e-05	0.000189	CcSEcCtD
Felbamate—Dysgeusia—Epirubicin—prostate cancer	3.19e-05	0.000189	CcSEcCtD
Felbamate—Nervousness—Epirubicin—prostate cancer	3.17e-05	0.000187	CcSEcCtD
Felbamate—Feeling abnormal—Capecitabine—prostate cancer	3.15e-05	0.000186	CcSEcCtD
Felbamate—Dizziness—Etoposide—prostate cancer	3.14e-05	0.000185	CcSEcCtD
Felbamate—Gastrointestinal pain—Capecitabine—prostate cancer	3.12e-05	0.000184	CcSEcCtD
Felbamate—Abdominal pain—Docetaxel—prostate cancer	3.12e-05	0.000184	CcSEcCtD
Felbamate—Body temperature increased—Docetaxel—prostate cancer	3.12e-05	0.000184	CcSEcCtD
Felbamate—Chills—Doxorubicin—prostate cancer	3.11e-05	0.000184	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Prednisone—prostate cancer	3.1e-05	0.000183	CcSEcCtD
Felbamate—Insomnia—Prednisone—prostate cancer	3.08e-05	0.000182	CcSEcCtD
Felbamate—Alopecia—Doxorubicin—prostate cancer	3.06e-05	0.000181	CcSEcCtD
Felbamate—Paraesthesia—Prednisone—prostate cancer	3.06e-05	0.00018	CcSEcCtD
Felbamate—Urticaria—Capecitabine—prostate cancer	3.03e-05	0.000179	CcSEcCtD
Felbamate—Ill-defined disorder—Epirubicin—prostate cancer	3.03e-05	0.000179	CcSEcCtD
Felbamate—Abdominal pain—Capecitabine—prostate cancer	3.02e-05	0.000178	CcSEcCtD
Felbamate—Body temperature increased—Capecitabine—prostate cancer	3.02e-05	0.000178	CcSEcCtD
Felbamate—Vomiting—Etoposide—prostate cancer	3.02e-05	0.000178	CcSEcCtD
Felbamate—Anaemia—Epirubicin—prostate cancer	3.01e-05	0.000178	CcSEcCtD
Felbamate—Agitation—Epirubicin—prostate cancer	3e-05	0.000177	CcSEcCtD
Felbamate—Dyspepsia—Prednisone—prostate cancer	3e-05	0.000177	CcSEcCtD
Felbamate—Rash—Etoposide—prostate cancer	2.99e-05	0.000177	CcSEcCtD
Felbamate—Dermatitis—Etoposide—prostate cancer	2.99e-05	0.000177	CcSEcCtD
Felbamate—Headache—Etoposide—prostate cancer	2.97e-05	0.000176	CcSEcCtD
Felbamate—Flatulence—Doxorubicin—prostate cancer	2.97e-05	0.000176	CcSEcCtD
Felbamate—Tension—Doxorubicin—prostate cancer	2.96e-05	0.000175	CcSEcCtD
Felbamate—Decreased appetite—Prednisone—prostate cancer	2.96e-05	0.000175	CcSEcCtD
Felbamate—Dysgeusia—Doxorubicin—prostate cancer	2.95e-05	0.000175	CcSEcCtD
Felbamate—Malaise—Epirubicin—prostate cancer	2.94e-05	0.000174	CcSEcCtD
Felbamate—Fatigue—Prednisone—prostate cancer	2.93e-05	0.000173	CcSEcCtD
Felbamate—Nervousness—Doxorubicin—prostate cancer	2.93e-05	0.000173	CcSEcCtD
Felbamate—Leukopenia—Epirubicin—prostate cancer	2.92e-05	0.000172	CcSEcCtD
Felbamate—Constipation—Prednisone—prostate cancer	2.91e-05	0.000172	CcSEcCtD
Felbamate—Palpitations—Epirubicin—prostate cancer	2.88e-05	0.00017	CcSEcCtD
Felbamate—Cough—Epirubicin—prostate cancer	2.85e-05	0.000168	CcSEcCtD
Felbamate—Asthenia—Docetaxel—prostate cancer	2.83e-05	0.000167	CcSEcCtD
Felbamate—Nausea—Etoposide—prostate cancer	2.82e-05	0.000167	CcSEcCtD
Felbamate—Hypertension—Epirubicin—prostate cancer	2.82e-05	0.000166	CcSEcCtD
Felbamate—Feeling abnormal—Prednisone—prostate cancer	2.8e-05	0.000166	CcSEcCtD
Felbamate—Ill-defined disorder—Doxorubicin—prostate cancer	2.8e-05	0.000165	CcSEcCtD
Felbamate—Pruritus—Docetaxel—prostate cancer	2.79e-05	0.000165	CcSEcCtD
Felbamate—Anaemia—Doxorubicin—prostate cancer	2.79e-05	0.000165	CcSEcCtD
Felbamate—Gastrointestinal pain—Prednisone—prostate cancer	2.78e-05	0.000164	CcSEcCtD
Felbamate—Chest pain—Epirubicin—prostate cancer	2.78e-05	0.000164	CcSEcCtD
Felbamate—Myalgia—Epirubicin—prostate cancer	2.78e-05	0.000164	CcSEcCtD
Felbamate—Arthralgia—Epirubicin—prostate cancer	2.78e-05	0.000164	CcSEcCtD
Felbamate—Agitation—Doxorubicin—prostate cancer	2.77e-05	0.000164	CcSEcCtD
Felbamate—Anxiety—Epirubicin—prostate cancer	2.77e-05	0.000163	CcSEcCtD
Felbamate—Discomfort—Epirubicin—prostate cancer	2.74e-05	0.000162	CcSEcCtD
Felbamate—Asthenia—Capecitabine—prostate cancer	2.74e-05	0.000162	CcSEcCtD
Felbamate—Malaise—Doxorubicin—prostate cancer	2.72e-05	0.000161	CcSEcCtD
Felbamate—Dry mouth—Epirubicin—prostate cancer	2.72e-05	0.00016	CcSEcCtD
Felbamate—Urticaria—Prednisone—prostate cancer	2.7e-05	0.00016	CcSEcCtD
Felbamate—Pruritus—Capecitabine—prostate cancer	2.7e-05	0.00016	CcSEcCtD
Felbamate—Leukopenia—Doxorubicin—prostate cancer	2.7e-05	0.00016	CcSEcCtD
Felbamate—Diarrhoea—Docetaxel—prostate cancer	2.7e-05	0.000159	CcSEcCtD
Felbamate—Abdominal pain—Prednisone—prostate cancer	2.69e-05	0.000159	CcSEcCtD
Felbamate—Body temperature increased—Prednisone—prostate cancer	2.69e-05	0.000159	CcSEcCtD
Felbamate—Confusional state—Epirubicin—prostate cancer	2.68e-05	0.000158	CcSEcCtD
Felbamate—Palpitations—Doxorubicin—prostate cancer	2.67e-05	0.000157	CcSEcCtD
Felbamate—Oedema—Epirubicin—prostate cancer	2.66e-05	0.000157	CcSEcCtD
Felbamate—Anaphylactic shock—Epirubicin—prostate cancer	2.66e-05	0.000157	CcSEcCtD
Felbamate—Infection—Epirubicin—prostate cancer	2.64e-05	0.000156	CcSEcCtD
Felbamate—Cough—Doxorubicin—prostate cancer	2.63e-05	0.000156	CcSEcCtD
Felbamate—Diarrhoea—Capecitabine—prostate cancer	2.61e-05	0.000154	CcSEcCtD
Felbamate—Dizziness—Docetaxel—prostate cancer	2.61e-05	0.000154	CcSEcCtD
Felbamate—Thrombocytopenia—Epirubicin—prostate cancer	2.61e-05	0.000154	CcSEcCtD
Felbamate—Hypertension—Doxorubicin—prostate cancer	2.61e-05	0.000154	CcSEcCtD
Felbamate—Tachycardia—Epirubicin—prostate cancer	2.6e-05	0.000153	CcSEcCtD
Felbamate—Hyperhidrosis—Epirubicin—prostate cancer	2.57e-05	0.000152	CcSEcCtD
Felbamate—Chest pain—Doxorubicin—prostate cancer	2.57e-05	0.000152	CcSEcCtD
Felbamate—Myalgia—Doxorubicin—prostate cancer	2.57e-05	0.000152	CcSEcCtD
Felbamate—Arthralgia—Doxorubicin—prostate cancer	2.57e-05	0.000152	CcSEcCtD
Felbamate—Anxiety—Doxorubicin—prostate cancer	2.56e-05	0.000151	CcSEcCtD
Felbamate—Discomfort—Doxorubicin—prostate cancer	2.54e-05	0.00015	CcSEcCtD
Felbamate—Anorexia—Epirubicin—prostate cancer	2.54e-05	0.00015	CcSEcCtD
Felbamate—Dizziness—Capecitabine—prostate cancer	2.53e-05	0.000149	CcSEcCtD
Felbamate—Dry mouth—Doxorubicin—prostate cancer	2.51e-05	0.000148	CcSEcCtD
Felbamate—Vomiting—Docetaxel—prostate cancer	2.51e-05	0.000148	CcSEcCtD
Felbamate—Rash—Docetaxel—prostate cancer	2.49e-05	0.000147	CcSEcCtD
Felbamate—Hypotension—Epirubicin—prostate cancer	2.49e-05	0.000147	CcSEcCtD
Felbamate—Dermatitis—Docetaxel—prostate cancer	2.49e-05	0.000147	CcSEcCtD
Felbamate—Confusional state—Doxorubicin—prostate cancer	2.48e-05	0.000147	CcSEcCtD
Felbamate—Headache—Docetaxel—prostate cancer	2.47e-05	0.000146	CcSEcCtD
Felbamate—Anaphylactic shock—Doxorubicin—prostate cancer	2.46e-05	0.000145	CcSEcCtD
Felbamate—Oedema—Doxorubicin—prostate cancer	2.46e-05	0.000145	CcSEcCtD
Felbamate—Infection—Doxorubicin—prostate cancer	2.45e-05	0.000144	CcSEcCtD
Felbamate—Asthenia—Prednisone—prostate cancer	2.44e-05	0.000144	CcSEcCtD
Felbamate—Vomiting—Capecitabine—prostate cancer	2.43e-05	0.000143	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.42e-05	0.000143	CcSEcCtD
Felbamate—Thrombocytopenia—Doxorubicin—prostate cancer	2.41e-05	0.000142	CcSEcCtD
Felbamate—Rash—Capecitabine—prostate cancer	2.41e-05	0.000142	CcSEcCtD
Felbamate—Pruritus—Prednisone—prostate cancer	2.41e-05	0.000142	CcSEcCtD
Felbamate—Insomnia—Epirubicin—prostate cancer	2.41e-05	0.000142	CcSEcCtD
Felbamate—Dermatitis—Capecitabine—prostate cancer	2.41e-05	0.000142	CcSEcCtD
Felbamate—Tachycardia—Doxorubicin—prostate cancer	2.4e-05	0.000142	CcSEcCtD
Felbamate—Headache—Capecitabine—prostate cancer	2.39e-05	0.000141	CcSEcCtD
Felbamate—Paraesthesia—Epirubicin—prostate cancer	2.39e-05	0.000141	CcSEcCtD
Felbamate—Hyperhidrosis—Doxorubicin—prostate cancer	2.38e-05	0.000141	CcSEcCtD
Felbamate—Dyspnoea—Epirubicin—prostate cancer	2.37e-05	0.00014	CcSEcCtD
Felbamate—Somnolence—Epirubicin—prostate cancer	2.37e-05	0.00014	CcSEcCtD
Felbamate—Anorexia—Doxorubicin—prostate cancer	2.35e-05	0.000139	CcSEcCtD
Felbamate—Nausea—Docetaxel—prostate cancer	2.34e-05	0.000138	CcSEcCtD
Felbamate—Dyspepsia—Epirubicin—prostate cancer	2.34e-05	0.000138	CcSEcCtD
Felbamate—Diarrhoea—Prednisone—prostate cancer	2.33e-05	0.000138	CcSEcCtD
Felbamate—Decreased appetite—Epirubicin—prostate cancer	2.31e-05	0.000137	CcSEcCtD
Felbamate—Hypotension—Doxorubicin—prostate cancer	2.3e-05	0.000136	CcSEcCtD
Felbamate—Fatigue—Epirubicin—prostate cancer	2.29e-05	0.000136	CcSEcCtD
Felbamate—Pain—Epirubicin—prostate cancer	2.28e-05	0.000134	CcSEcCtD
Felbamate—Constipation—Epirubicin—prostate cancer	2.28e-05	0.000134	CcSEcCtD
Felbamate—Nausea—Capecitabine—prostate cancer	2.27e-05	0.000134	CcSEcCtD
Felbamate—Dizziness—Prednisone—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.24e-05	0.000133	CcSEcCtD
Felbamate—Insomnia—Doxorubicin—prostate cancer	2.23e-05	0.000132	CcSEcCtD
Felbamate—Paraesthesia—Doxorubicin—prostate cancer	2.21e-05	0.000131	CcSEcCtD
Felbamate—Dyspnoea—Doxorubicin—prostate cancer	2.2e-05	0.00013	CcSEcCtD
Felbamate—Feeling abnormal—Epirubicin—prostate cancer	2.19e-05	0.00013	CcSEcCtD
Felbamate—Somnolence—Doxorubicin—prostate cancer	2.19e-05	0.000129	CcSEcCtD
Felbamate—Gastrointestinal pain—Epirubicin—prostate cancer	2.18e-05	0.000129	CcSEcCtD
Felbamate—Dyspepsia—Doxorubicin—prostate cancer	2.17e-05	0.000128	CcSEcCtD
Felbamate—Vomiting—Prednisone—prostate cancer	2.16e-05	0.000128	CcSEcCtD
Felbamate—Rash—Prednisone—prostate cancer	2.15e-05	0.000127	CcSEcCtD
Felbamate—Dermatitis—Prednisone—prostate cancer	2.14e-05	0.000127	CcSEcCtD
Felbamate—Decreased appetite—Doxorubicin—prostate cancer	2.14e-05	0.000126	CcSEcCtD
Felbamate—Headache—Prednisone—prostate cancer	2.13e-05	0.000126	CcSEcCtD
Felbamate—Fatigue—Doxorubicin—prostate cancer	2.12e-05	0.000125	CcSEcCtD
Felbamate—Urticaria—Epirubicin—prostate cancer	2.11e-05	0.000125	CcSEcCtD
Felbamate—Constipation—Doxorubicin—prostate cancer	2.11e-05	0.000124	CcSEcCtD
Felbamate—Pain—Doxorubicin—prostate cancer	2.11e-05	0.000124	CcSEcCtD
Felbamate—Abdominal pain—Epirubicin—prostate cancer	2.1e-05	0.000124	CcSEcCtD
Felbamate—Body temperature increased—Epirubicin—prostate cancer	2.1e-05	0.000124	CcSEcCtD
Felbamate—Feeling abnormal—Doxorubicin—prostate cancer	2.03e-05	0.00012	CcSEcCtD
Felbamate—Nausea—Prednisone—prostate cancer	2.02e-05	0.000119	CcSEcCtD
Felbamate—Gastrointestinal pain—Doxorubicin—prostate cancer	2.01e-05	0.000119	CcSEcCtD
Felbamate—Urticaria—Doxorubicin—prostate cancer	1.96e-05	0.000116	CcSEcCtD
Felbamate—Body temperature increased—Doxorubicin—prostate cancer	1.95e-05	0.000115	CcSEcCtD
Felbamate—Abdominal pain—Doxorubicin—prostate cancer	1.95e-05	0.000115	CcSEcCtD
Felbamate—Asthenia—Epirubicin—prostate cancer	1.91e-05	0.000113	CcSEcCtD
Felbamate—Pruritus—Epirubicin—prostate cancer	1.88e-05	0.000111	CcSEcCtD
Felbamate—Diarrhoea—Epirubicin—prostate cancer	1.82e-05	0.000108	CcSEcCtD
Felbamate—Asthenia—Doxorubicin—prostate cancer	1.77e-05	0.000104	CcSEcCtD
Felbamate—Dizziness—Epirubicin—prostate cancer	1.76e-05	0.000104	CcSEcCtD
Felbamate—Pruritus—Doxorubicin—prostate cancer	1.74e-05	0.000103	CcSEcCtD
Felbamate—Vomiting—Epirubicin—prostate cancer	1.69e-05	9.99e-05	CcSEcCtD
Felbamate—Diarrhoea—Doxorubicin—prostate cancer	1.68e-05	9.95e-05	CcSEcCtD
Felbamate—Rash—Epirubicin—prostate cancer	1.68e-05	9.91e-05	CcSEcCtD
Felbamate—Dermatitis—Epirubicin—prostate cancer	1.68e-05	9.9e-05	CcSEcCtD
Felbamate—Headache—Epirubicin—prostate cancer	1.67e-05	9.85e-05	CcSEcCtD
Felbamate—Dizziness—Doxorubicin—prostate cancer	1.63e-05	9.62e-05	CcSEcCtD
Felbamate—Nausea—Epirubicin—prostate cancer	1.58e-05	9.34e-05	CcSEcCtD
Felbamate—Vomiting—Doxorubicin—prostate cancer	1.57e-05	9.25e-05	CcSEcCtD
Felbamate—Rash—Doxorubicin—prostate cancer	1.55e-05	9.17e-05	CcSEcCtD
Felbamate—Dermatitis—Doxorubicin—prostate cancer	1.55e-05	9.16e-05	CcSEcCtD
Felbamate—Headache—Doxorubicin—prostate cancer	1.54e-05	9.11e-05	CcSEcCtD
Felbamate—Nausea—Doxorubicin—prostate cancer	1.46e-05	8.64e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—GSTA4—prostate cancer	1.03e-05	0.000139	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.02e-05	0.000138	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SULT1E1—prostate cancer	1.02e-05	0.000138	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SRD5A1—prostate cancer	1.02e-05	0.000138	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA2—prostate cancer	1e-05	0.000135	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	9.93e-06	0.000134	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SULT1A1—prostate cancer	9.92e-06	0.000134	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCG5—prostate cancer	9.92e-06	0.000134	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ADI1—prostate cancer	9.79e-06	0.000132	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GRHL1—prostate cancer	9.79e-06	0.000132	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CBR1—prostate cancer	9.79e-06	0.000132	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TST—prostate cancer	9.79e-06	0.000132	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PSAT1—prostate cancer	9.79e-06	0.000132	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CSAD—prostate cancer	9.79e-06	0.000132	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	9.78e-06	0.000132	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ACSL4—prostate cancer	9.75e-06	0.000131	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HSD17B3—prostate cancer	9.75e-06	0.000131	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA1—prostate cancer	9.68e-06	0.00013	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	9.64e-06	0.00013	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTO1—prostate cancer	9.58e-06	0.000129	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HSD3B2—prostate cancer	9.58e-06	0.000129	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NAT2—prostate cancer	9.58e-06	0.000129	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—prostate cancer	9.44e-06	0.000127	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—UMPS—prostate cancer	9.35e-06	0.000126	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PHGDH—prostate cancer	9.35e-06	0.000126	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ARG2—prostate cancer	9.35e-06	0.000126	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	9.3e-06	0.000125	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PLCB2—prostate cancer	9.18e-06	0.000124	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—LRP2—prostate cancer	9.18e-06	0.000124	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP2C18—prostate cancer	9.18e-06	0.000124	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—LDHB—prostate cancer	9.17e-06	0.000123	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CKMT2—prostate cancer	9.1e-06	0.000123	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—UGT2B17—prostate cancer	9.1e-06	0.000123	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GRHPR—prostate cancer	9.1e-06	0.000123	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—UGT2B15—prostate cancer	9.1e-06	0.000123	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—P4HB—prostate cancer	9e-06	0.000121	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP3A5—prostate cancer	9e-06	0.000121	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC22A1—prostate cancer	8.76e-06	0.000118	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT1—prostate cancer	8.71e-06	0.000117	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PDHA1—prostate cancer	8.69e-06	0.000117	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—UCP3—prostate cancer	8.69e-06	0.000117	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA3—prostate cancer	8.69e-06	0.000117	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TCN2—prostate cancer	8.69e-06	0.000117	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTM3—prostate cancer	8.55e-06	0.000115	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—RFK—prostate cancer	8.55e-06	0.000115	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MBTPS1—prostate cancer	8.55e-06	0.000115	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NAGLU—prostate cancer	8.55e-06	0.000115	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SULT2B1—prostate cancer	8.55e-06	0.000115	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AOX1—prostate cancer	8.55e-06	0.000115	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PGAM2—prostate cancer	8.55e-06	0.000115	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SULT2A1—prostate cancer	8.54e-06	0.000115	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MED12—prostate cancer	8.4e-06	0.000113	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GNG5—prostate cancer	8.33e-06	0.000112	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC22A3—prostate cancer	8.29e-06	0.000112	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HSD3B1—prostate cancer	8.29e-06	0.000112	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP3A43—prostate cancer	8.11e-06	0.000109	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SRD5A2—prostate cancer	8.11e-06	0.000109	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AMACR—prostate cancer	8.11e-06	0.000109	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NAT1—prostate cancer	8.11e-06	0.000109	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—DEGS1—prostate cancer	8.11e-06	0.000109	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	8.04e-06	0.000108	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NCOA3—prostate cancer	8.03e-06	0.000108	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TBXAS1—prostate cancer	7.95e-06	0.000107	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA4—prostate cancer	7.95e-06	0.000107	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.77e-06	0.000105	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA2—prostate cancer	7.74e-06	0.000104	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HSD17B1—prostate cancer	7.74e-06	0.000104	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HPGDS—prostate cancer	7.66e-06	0.000103	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SULT1A1—prostate cancer	7.65e-06	0.000103	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCG5—prostate cancer	7.65e-06	0.000103	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP2C19—prostate cancer	7.61e-06	0.000102	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA1—prostate cancer	7.47e-06	0.000101	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ACHE—prostate cancer	7.43e-06	0.0001	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTT1—prostate cancer	7.43e-06	0.0001	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NAT2—prostate cancer	7.39e-06	9.95e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTO1—prostate cancer	7.39e-06	9.95e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HSD3B2—prostate cancer	7.39e-06	9.95e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP2A6—prostate cancer	7.34e-06	9.88e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKR1C3—prostate cancer	7.14e-06	9.61e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.1e-06	9.57e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PRKACB—prostate cancer	7.1e-06	9.56e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PLCB2—prostate cancer	7.08e-06	9.54e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—LRP2—prostate cancer	7.08e-06	9.54e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2C18—prostate cancer	7.08e-06	9.54e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP17A1—prostate cancer	7.03e-06	9.46e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—P4HB—prostate cancer	6.95e-06	9.35e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.89e-06	9.28e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HPGD—prostate cancer	6.89e-06	9.28e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC22A1—prostate cancer	6.76e-06	9.1e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NCOA2—prostate cancer	6.7e-06	9.02e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.68e-06	8.99e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SULT2A1—prostate cancer	6.59e-06	8.87e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TNFRSF21—prostate cancer	6.48e-06	8.73e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MED12—prostate cancer	6.48e-06	8.72e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GNG5—prostate cancer	6.43e-06	8.66e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC5A5—prostate cancer	6.39e-06	8.6e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP7B1—prostate cancer	6.31e-06	8.49e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTAP—prostate cancer	6.31e-06	8.49e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NCOA3—prostate cancer	6.19e-06	8.34e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NQO1—prostate cancer	6.17e-06	8.31e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SRD5A1—prostate cancer	6.15e-06	8.28e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SULT1E1—prostate cancer	6.15e-06	8.28e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.08e-06	8.19e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TH—prostate cancer	6.08e-06	8.19e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP3A4—prostate cancer	6.02e-06	8.1e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1B1—prostate cancer	5.92e-06	7.97e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HPGDS—prostate cancer	5.91e-06	7.95e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.86e-06	7.89e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ACSL4—prostate cancer	5.86e-06	7.89e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GGT1—prostate cancer	5.73e-06	7.72e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ACHE—prostate cancer	5.73e-06	7.71e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTT1—prostate cancer	5.73e-06	7.71e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2A6—prostate cancer	5.66e-06	7.63e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NCOA1—prostate cancer	5.64e-06	7.6e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.64e-06	7.6e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ARG2—prostate cancer	5.62e-06	7.57e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—UMPS—prostate cancer	5.62e-06	7.57e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PHGDH—prostate cancer	5.62e-06	7.57e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP19A1—prostate cancer	5.56e-06	7.49e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—LDHB—prostate cancer	5.51e-06	7.42e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKR1C3—prostate cancer	5.51e-06	7.42e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PRKACB—prostate cancer	5.48e-06	7.38e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP17A1—prostate cancer	5.42e-06	7.3e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.41e-06	7.29e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—RXRA—prostate cancer	5.37e-06	7.23e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.35e-06	7.2e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—UCP3—prostate cancer	5.23e-06	7.04e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA3—prostate cancer	5.23e-06	7.04e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TCN2—prostate cancer	5.23e-06	7.04e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PDHA1—prostate cancer	5.23e-06	7.04e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—COMT—prostate cancer	5.17e-06	6.96e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NCOA2—prostate cancer	5.17e-06	6.96e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTP1—prostate cancer	5.15e-06	6.93e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ITPR1—prostate cancer	5.06e-06	6.82e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.98e-06	6.71e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.98e-06	6.71e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC5A5—prostate cancer	4.93e-06	6.64e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2E1—prostate cancer	4.81e-06	6.48e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TYMS—prostate cancer	4.78e-06	6.44e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.78e-06	6.44e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA4—prostate cancer	4.78e-06	6.44e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NQO1—prostate cancer	4.76e-06	6.41e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTM1—prostate cancer	4.73e-06	6.37e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TH—prostate cancer	4.69e-06	6.32e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.66e-06	6.28e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA2—prostate cancer	4.66e-06	6.27e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP3A4—prostate cancer	4.64e-06	6.25e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—LPL—prostate cancer	4.64e-06	6.25e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.62e-06	6.22e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.6e-06	6.19e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCG5—prostate cancer	4.6e-06	6.19e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1B1—prostate cancer	4.56e-06	6.15e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA1—prostate cancer	4.49e-06	6.05e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1A1—prostate cancer	4.48e-06	6.04e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ERCC2—prostate cancer	4.45e-06	5.99e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTO1—prostate cancer	4.44e-06	5.98e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.44e-06	5.98e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NAT2—prostate cancer	4.44e-06	5.98e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GGT1—prostate cancer	4.42e-06	5.95e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NCOA1—prostate cancer	4.35e-06	5.86e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP19A1—prostate cancer	4.29e-06	5.78e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PLCB2—prostate cancer	4.26e-06	5.74e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.26e-06	5.74e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—LRP2—prostate cancer	4.26e-06	5.74e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MTHFR—prostate cancer	4.18e-06	5.63e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—P4HB—prostate cancer	4.18e-06	5.62e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—RXRA—prostate cancer	4.14e-06	5.58e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPARA—prostate cancer	4.1e-06	5.52e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.06e-06	5.47e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.03e-06	5.42e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—COMT—prostate cancer	3.99e-06	5.37e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTP1—prostate cancer	3.97e-06	5.35e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.96e-06	5.33e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ITPR1—prostate cancer	3.91e-06	5.26e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MED12—prostate cancer	3.9e-06	5.25e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GNG5—prostate cancer	3.87e-06	5.2e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CAV1—prostate cancer	3.86e-06	5.19e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.84e-06	5.17e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NCOA3—prostate cancer	3.72e-06	5.01e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TYMS—prostate cancer	3.69e-06	4.97e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTM1—prostate cancer	3.65e-06	4.91e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—LPL—prostate cancer	3.58e-06	4.82e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HPGDS—prostate cancer	3.55e-06	4.78e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.53e-06	4.75e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CG—prostate cancer	3.51e-06	4.73e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1A1—prostate cancer	3.46e-06	4.66e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTT1—prostate cancer	3.44e-06	4.64e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ACHE—prostate cancer	3.44e-06	4.64e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ERCC2—prostate cancer	3.43e-06	4.62e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.41e-06	4.59e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—INS—prostate cancer	3.32e-06	4.48e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.31e-06	4.46e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PRKACB—prostate cancer	3.3e-06	4.44e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.26e-06	4.39e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CREBBP—prostate cancer	3.26e-06	4.38e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MTHFR—prostate cancer	3.22e-06	4.34e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPARA—prostate cancer	3.16e-06	4.26e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NCOA2—prostate cancer	3.11e-06	4.18e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CD—prostate cancer	3.09e-06	4.16e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CAV1—prostate cancer	2.97e-06	4.01e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.96e-06	3.99e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NOS3—prostate cancer	2.92e-06	3.93e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.9e-06	3.9e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NQO1—prostate cancer	2.86e-06	3.86e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.84e-06	3.83e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TH—prostate cancer	2.82e-06	3.8e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.74e-06	3.7e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.71e-06	3.65e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CB—prostate cancer	2.69e-06	3.62e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS2—prostate cancer	2.67e-06	3.59e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GGT1—prostate cancer	2.66e-06	3.58e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NCOA1—prostate cancer	2.62e-06	3.53e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.58e-06	3.48e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—INS—prostate cancer	2.56e-06	3.45e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CREBBP—prostate cancer	2.51e-06	3.38e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—RXRA—prostate cancer	2.49e-06	3.35e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—COMT—prostate cancer	2.4e-06	3.23e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTP1—prostate cancer	2.39e-06	3.22e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.38e-06	3.21e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ITPR1—prostate cancer	2.35e-06	3.16e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTEN—prostate cancer	2.33e-06	3.13e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NOS3—prostate cancer	2.25e-06	3.03e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TYMS—prostate cancer	2.22e-06	2.99e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—EP300—prostate cancer	2.22e-06	2.99e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTM1—prostate cancer	2.19e-06	2.95e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—LPL—prostate cancer	2.15e-06	2.9e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.08e-06	2.8e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.08e-06	2.8e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ERCC2—prostate cancer	2.06e-06	2.78e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS2—prostate cancer	2.06e-06	2.77e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTHFR—prostate cancer	1.94e-06	2.61e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPARA—prostate cancer	1.9e-06	2.56e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTEN—prostate cancer	1.79e-06	2.42e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CAV1—prostate cancer	1.79e-06	2.41e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—EP300—prostate cancer	1.71e-06	2.3e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.64e-06	2.21e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.63e-06	2.19e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—INS—prostate cancer	1.54e-06	2.08e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CREBBP—prostate cancer	1.51e-06	2.03e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.43e-06	1.93e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NOS3—prostate cancer	1.35e-06	1.82e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKT1—prostate cancer	1.34e-06	1.8e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.27e-06	1.7e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.25e-06	1.68e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS2—prostate cancer	1.24e-06	1.67e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTEN—prostate cancer	1.08e-06	1.45e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKT1—prostate cancer	1.03e-06	1.39e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—EP300—prostate cancer	1.03e-06	1.39e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.61e-07	1.02e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKT1—prostate cancer	6.22e-07	8.37e-06	CbGpPWpGaD
